SCHEMBL20547294

SCHEMBL20547294

CC(C)(C)OC(=O)N1CCc2c(-c3ccccc3Cl)nn(C(=O)OC(C)(C)C)c2CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.55
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
POLB P06746 1/20 0.41
STS P08842 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PDK4 Q16654 1/20 0.40
DGAT2 Q96PD7 3/20 0.40
PARP1 P09874 1/20 0.39
TNKS2 Q9H2K2 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
PLA2G7 Q13093 1/20 0.39
MGLL Q99685 1/20 0.39
ABHD6 Q9BV23 1/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547193 0.88 RORC (0.48) RORCPDK4PARP1TNKS2PARP2
SCHEMBL20547144 0.87 RORC (0.55) RORCPDK4PARP1TNKS2PARP2
SCHEMBL20547247 0.84 CKS1B (0.51) RORCCKS1BSKP1SKP2GPR119
SCHEMBL20547213 0.81 RORC (0.50) RORCPOLBSTS
SCHEMBL20547291 0.79 GPR119 (0.45) RORCMEN1KMT2ACKS1BSKP1
SCHEMBL20547216 0.78 RORC (0.47) RORCCKS1BSKP1SKP2GPR119
SCHEMBL20547249 0.77 RORC (0.50) RORC
SCHEMBL24417770 0.73 P2RX7 (0.52) RORCCKS1BSKP1SKP2GPR119
SCHEMBL16518216 0.73 PTGDR2 (0.49) PDK4PARP1TNKS2PARP2
SCHEMBL2073807 0.72 PTGS2 (0.57) MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A RORC 1569/4885CNR1 110/4885CNR2 112/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A RORC 1569/4885CNR1 110/4885CNR2 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.